APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis B Vaccines

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

Selected research

Market Analysis & Forecast

Global Hepatitis B Vaccines Market Analysis and Forecast 2026-2032

28 December 2025197 pages

Choose your research edition.

Industry ResearchHepatitis B Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis B Vaccines Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Hepatitis B Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis B Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis B Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.

The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.

Read the full market overview

Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.

Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report presents an overview of global market for Hepatitis B Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hepatitis B Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Hepatitis B Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hepatitis B Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hepatitis B Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hepatitis B Vaccines sales, projected growth trends, production technology, application and end-user industry.

Hepatitis B Vaccines Segment by Company

GSK

NCPC

Merck

Bio Kangtai

Dynavax

Hissen

KM Biologics

LG Life Sciences

Serum Institute

Hepatitis B Vaccines Segment by Type

Yeast Derived

CHO Derived

Hepatitis B Vaccines Segment by Application

Children

Adult

Hepatitis B Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis B Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis B Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis B Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hepatitis B Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis B Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hepatitis B Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Yeast Derived Major Manufacturers Table 3. CHO Derived Major Manufacturers Table 4. Global Hepatitis B Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Children Major Manufacturers Table 6. Adult Major Manufacturers Table 7. Hepatitis B Vaccines Industry Trends Table 8. Hepatitis B Vaccines Industry Drivers Table 9. Hepatitis B Vaccines Industry Opportunities and Challenges Table 10. Hepatitis B Vaccines Industry Restraints Table 11. Global Hepatitis B Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Hepatitis B Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Hepatitis B Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Hepatitis B Vaccines Revenue Market Share by Region (2021-2026) Table 15. Global Hepatitis B Vaccines Revenue Market Share by Region (2027-2032) Table 16. Global Hepatitis B Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 17. Global Hepatitis B Vaccines Sales by Region (2021-2026) & (M Doses) Table 18. Global Hepatitis B Vaccines Sales by Region (2027-2032) & (M Doses) Table 19. Global Hepatitis B Vaccines Sales Market Share by Region (2021-2026) Table 20. Global Hepatitis B Vaccines Sales Market Share by Region (2027-2032) Table 21. Global Hepatitis B Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Hepatitis B Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2021-2026) Table 25. Global Hepatitis B Vaccines Sales Price (USD/Doses) of Manufacturers (2021-2026) Table 26. Global Hepatitis B Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Hepatitis B Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Hepatitis B Vaccines Manufacturers, Product Type & Application Table 29. Global Hepatitis B Vaccines Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Hepatitis B Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Hepatitis B Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Hepatitis B Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Hepatitis B Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Hepatitis B Vaccines Revenue Market Share by Type (2021-2026) Table 36. Global Hepatitis B Vaccines Revenue Market Share by Type (2027-2032) Table 37. Global Hepatitis B Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 38. Global Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 39. Global Hepatitis B Vaccines Sales by Type (2027-2032) & (M Doses) Table 40. Global Hepatitis B Vaccines Sales Market Share by Type (2021-2026) Table 41. Global Hepatitis B Vaccines Sales Market Share by Type (2027-2032) Table 42. Global Hepatitis B Vaccines Price by Type (2021-2026) & (USD/Doses) Table 43. Global Hepatitis B Vaccines Price by Type (2027-2032) & (USD/Doses) Table 44. Global Hepatitis B Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Hepatitis B Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Hepatitis B Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Hepatitis B Vaccines Revenue Market Share by Application (2021-2026) Table 48. Global Hepatitis B Vaccines Revenue Market Share by Application (2027-2032) Table 49. Global Hepatitis B Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 50. Global Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 51. Global Hepatitis B Vaccines Sales by Application (2027-2032) & (M Doses) Table 52. Global Hepatitis B Vaccines Sales Market Share by Application (2021-2026) Table 53. Global Hepatitis B Vaccines Sales Market Share by Application (2027-2032) Table 54. Global Hepatitis B Vaccines Price by Application (2021-2026) & (USD/Doses) Table 55. Global Hepatitis B Vaccines Price by Application (2027-2032) & (USD/Doses) Table 56. GSK Company Information Table 57. GSK Business Overview Table 58. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 59. GSK Hepatitis B Vaccines Product Portfolio Table 60. GSK Recent Development Table 61. NCPC Company Information Table 62. NCPC Business Overview Table 63. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 64. NCPC Hepatitis B Vaccines Product Portfolio Table 65. NCPC Recent Development Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 69. Merck Hepatitis B Vaccines Product Portfolio Table 70. Merck Recent Development Table 71. Bio Kangtai Company Information Table 72. Bio Kangtai Business Overview Table 73. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 74. Bio Kangtai Hepatitis B Vaccines Product Portfolio Table 75. Bio Kangtai Recent Development Table 76. Dynavax Company Information Table 77. Dynavax Business Overview Table 78. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 79. Dynavax Hepatitis B Vaccines Product Portfolio Table 80. Dynavax Recent Development Table 81. Hissen Company Information Table 82. Hissen Business Overview Table 83. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 84. Hissen Hepatitis B Vaccines Product Portfolio Table 85. Hissen Recent Development Table 86. KM Biologics Company Information Table 87. KM Biologics Business Overview Table 88. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 89. KM Biologics Hepatitis B Vaccines Product Portfolio Table 90. KM Biologics Recent Development Table 91. LG Life Sciences Company Information Table 92. LG Life Sciences Business Overview Table 93. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 94. LG Life Sciences Hepatitis B Vaccines Product Portfolio Table 95. LG Life Sciences Recent Development Table 96. Serum Institute Company Information Table 97. Serum Institute Business Overview Table 98. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 99. Serum Institute Hepatitis B Vaccines Product Portfolio Table 100. Serum Institute Recent Development Table 101. North America Hepatitis B Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Hepatitis B Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 104. North America Hepatitis B Vaccines Sales by Type (2027-2032) & (M Doses) Table 105. North America Hepatitis B Vaccines Sales Price by Type (2021-2026) & (USD/Doses) Table 106. North America Hepatitis B Vaccines Sales Price by Type (2027-2032) & (USD/Doses) Table 107. North America Hepatitis B Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Hepatitis B Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 110. North America Hepatitis B Vaccines Sales by Application (2027-2032) & (M Doses) Table 111. North America Hepatitis B Vaccines Sales Price by Application (2021-2026) & (USD/Doses) Table 112. North America Hepatitis B Vaccines Sales Price by Application (2027-2032) & (USD/Doses) Table 113. North America Hepatitis B Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Hepatitis B Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Hepatitis B Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Hepatitis B Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 117. North America Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 118. North America Hepatitis B Vaccines Sales by Country (2027-2032) & (M Doses) Table 119. North America Hepatitis B Vaccines Sales Price by Country (2021-2026) & (USD/Doses) Table 120. North America Hepatitis B Vaccines Sales Price by Country (2027-2032) & (USD/Doses) Table 121. United States Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 122. Canada Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 123. Mexico Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 124. Europe Hepatitis B Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Hepatitis B Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 127. Europe Hepatitis B Vaccines Sales by Type (2027-2032) & (M Doses) Table 128. Europe Hepatitis B Vaccines Sales Price by Type (2021-2026) & (USD/Doses) Table 129. Europe Hepatitis B Vaccines Sales Price by Type (2027-2032) & (USD/Doses) Table 130. Europe Hepatitis B Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Hepatitis B Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 133. Europe Hepatitis B Vaccines Sales by Application (2027-2032) & (M Doses) Table 134. Europe Hepatitis B Vaccines Sales Price by Application (2021-2026) & (USD/Doses) Table 135. Europe Hepatitis B Vaccines Sales Price by Application (2027-2032) & (USD/Doses) Table 136. Europe Hepatitis B Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Hepatitis B Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Hepatitis B Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Hepatitis B Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 140. Europe Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 141. Europe Hepatitis B Vaccines Sales by Country (2027-2032) & (M Doses) Table 142. Europe Hepatitis B Vaccines Sales Price by Country (2021-2026) & (USD/Doses) Table 143. Europe Hepatitis B Vaccines Sales Price by Country (2027-2032) & (USD/Doses) Table 144. Germany Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 145. France Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 146. U.K. Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 147. Italy Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 148. Russia Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 149. Spain Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 152. Sweden Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 153. Poland Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 154. China Hepatitis B Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 155. China Hepatitis B Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 156. China Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 157. China Hepatitis B Vaccines Sales by Type (2027-2032) & (M Doses) Table 158. China Hepatitis B Vaccines Sales Price by Type (2021-2026) & (USD/Doses) Table 159. China Hepatitis B Vaccines Sales Price by Type (2027-2032) & (USD/Doses) Table 160. China Hepatitis B Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 161. China Hepatitis B Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 162. China Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 163. China Hepatitis B Vaccines Sales by Application (2027-2032) & (M Doses) Table 164. China Hepatitis B Vaccines Sales Price by Application (2021-2026) & (USD/Doses) Table 165. China Hepatitis B Vaccines Sales Price by Application (2027-2032) & (USD/Doses) Table 166. Asia Hepatitis B Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Hepatitis B Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 169. Asia Hepatitis B Vaccines Sales by Type (2027-2032) & (M Doses) Table 170. Asia Hepatitis B Vaccines Sales Price by Type (2021-2026) & (USD/Doses) Table 171. Asia Hepatitis B Vaccines Sales Price by Type (2027-2032) & (USD/Doses) Table 172. Asia Hepatitis B Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Hepatitis B Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 175. Asia Hepatitis B Vaccines Sales by Application (2027-2032) & (M Doses) Table 176. Asia Hepatitis B Vaccines Sales Price by Application (2021-2026) & (USD/Doses) Table 177. Asia Hepatitis B Vaccines Sales Price by Application (2027-2032) & (USD/Doses) Table 178. Asia Hepatitis B Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Hepatitis B Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Hepatitis B Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Hepatitis B Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 182. Asia Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 183. Asia Hepatitis B Vaccines Sales by Country (2027-2032) & (M Doses) Table 184. Asia Hepatitis B Vaccines Sales Price by Country (2021-2026) & (USD/Doses) Table 185. Asia Hepatitis B Vaccines Sales Price by Country (2027-2032) & (USD/Doses) Table 186. Japan Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 187. South Korea Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 188. India Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 189. Australia Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Hepatitis B Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Hepatitis B Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 195. SAMEA Hepatitis B Vaccines Sales by Type (2027-2032) & (M Doses) Table 196. SAMEA Hepatitis B Vaccines Sales Price by Type (2021-2026) & (USD/Doses) Table 197. SAMEA Hepatitis B Vaccines Sales Price by Type (2027-2032) & (USD/Doses) Table 198. SAMEA Hepatitis B Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Hepatitis B Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 201. SAMEA Hepatitis B Vaccines Sales by Application (2027-2032) & (M Doses) Table 202. SAMEA Hepatitis B Vaccines Sales Price by Application (2021-2026) & (USD/Doses) Table 203. SAMEA Hepatitis B Vaccines Sales Price by Application (2027-2032) & (USD/Doses) Table 204. SAMEA Hepatitis B Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Hepatitis B Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Hepatitis B Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Hepatitis B Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 208. SAMEA Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 209. SAMEA Hepatitis B Vaccines Sales by Country (2027-2032) & (M Doses) Table 210. SAMEA Hepatitis B Vaccines Sales Price by Country (2021-2026) & (USD/Doses) Table 211. SAMEA Hepatitis B Vaccines Sales Price by Country (2027-2032) & (USD/Doses) Table 212. Brazil Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 213. Argentina Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 214. Chile Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 215. Colombia Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 216. Peru Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 218. Israel Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 219. UAE Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 220. Turkey Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 221. Iran Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 222. Egypt Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Hepatitis B Vaccines Distributors List Table 226. Hepatitis B Vaccines Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Hepatitis B Vaccines Image Figure 2. Global Hepatitis B Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatitis B Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Yeast Derived Image Figure 5. CHO Derived Image Figure 6. Global Hepatitis B Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hepatitis B Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Children Image Figure 9. Adult Image Figure 10. Global Hepatitis B Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Figure 12. Global Hepatitis B Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Hepatitis B Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Hepatitis B Vaccines Revenue Market Share by Region (2021-2032) Figure 15. Global Hepatitis B Vaccines Sales (2021-2032) & (M Doses) Figure 16. Global Hepatitis B Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 17. Global Hepatitis B Vaccines Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Hepatitis B Vaccines Sales YoY (2021-2032) & (M Doses) Figure 19. Europe Hepatitis B Vaccines Sales YoY (2021-2032) & (M Doses) Figure 20. China Hepatitis B Vaccines Sales YoY (2021-2032) & (M Doses) Figure 21. Asia (Excluding China) Hepatitis B Vaccines Sales YoY (2021-2032) & (M Doses) Figure 22. South America, Middle East and Africa Hepatitis B Vaccines Sales YoY (2021-2032) & (M Doses) Figure 23. Global Hepatitis B Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Hepatitis B Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Hepatitis B Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Hepatitis B Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Hepatitis B Vaccines Revenue Market Share by Type (2021-2032) Figure 29. Global Hepatitis B Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 30. Global Hepatitis B Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Hepatitis B Vaccines Sales Market Share by Type (2021-2032) Figure 32. Global Hepatitis B Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Hepatitis B Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Hepatitis B Vaccines Revenue Market Share by Application (2021-2032) Figure 35. Global Hepatitis B Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 36. Global Hepatitis B Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Hepatitis B Vaccines Sales Market Share by Application (2021-2032) Figure 38. North America Hepatitis B Vaccines Revenue Share by Type (2021-2032) Figure 39. North America Hepatitis B Vaccines Sales Share by Type (2021-2032) Figure 40. North America Hepatitis B Vaccines Revenue Share by Application (2021-2032) Figure 41. North America Hepatitis B Vaccines Sales Share by Application (2021-2032) Figure 42. North America Hepatitis B Vaccines Revenue Share by Country (2021-2032) Figure 43. North America Hepatitis B Vaccines Sales Share by Country (2021-2032) Figure 44. Europe Hepatitis B Vaccines Revenue Share by Type (2021-2032) Figure 45. Europe Hepatitis B Vaccines Sales Share by Type (2021-2032) Figure 46. Europe Hepatitis B Vaccines Revenue Share by Application (2021-2032) Figure 47. Europe Hepatitis B Vaccines Sales Share by Application (2021-2032) Figure 48. Europe Hepatitis B Vaccines Revenue Share by Country (2021-2032) Figure 49. Europe Hepatitis B Vaccines Sales Share by Country (2021-2032) Figure 50. China Hepatitis B Vaccines Revenue Share by Type (2021-2032) Figure 51. China Hepatitis B Vaccines Sales Share by Type (2021-2032) Figure 52. China Hepatitis B Vaccines Revenue Share by Application (2021-2032) Figure 53. China Hepatitis B Vaccines Sales Share by Application (2021-2032) Figure 54. Asia Hepatitis B Vaccines Revenue Share by Type (2021-2032) Figure 55. Asia Hepatitis B Vaccines Sales Share by Type (2021-2032) Figure 56. Asia Hepatitis B Vaccines Revenue Share by Application (2021-2032) Figure 57. Asia Hepatitis B Vaccines Sales Share by Application (2021-2032) Figure 58. Asia Hepatitis B Vaccines Revenue Share by Country (2021-2032) Figure 59. Asia Hepatitis B Vaccines Sales Share by Country (2021-2032) Figure 60. SAMEA Hepatitis B Vaccines Revenue Share by Type (2021-2032) Figure 61. SAMEA Hepatitis B Vaccines Sales Share by Type (2021-2032) Figure 62. SAMEA Hepatitis B Vaccines Revenue Share by Application (2021-2032) Figure 63. SAMEA Hepatitis B Vaccines Sales Share by Application (2021-2032) Figure 64. SAMEA Hepatitis B Vaccines Revenue Share by Country (2021-2032) Figure 65. SAMEA Hepatitis B Vaccines Sales Share by Country (2021-2032) Figure 66. Hepatitis B Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Hepatitis B Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast Derived
  • CHO Derived
Applications
  • Children
  • Adult
Companies covered
  • GSK
  • NCPC
  • Merck
  • Bio Kangtai
  • Dynavax
  • Hissen
  • KM Biologics
  • LG Life Sciences
  • Serum Institute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hepatitis B Vaccines Market by Type
  3. 1.2.1 Global Hepatitis B Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Yeast Derived
  5. 1.2.3 CHO Derived
  6. 1.3 Hepatitis B Vaccines Market by Application
  7. 1.3.1 Global Hepatitis B Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Children
  9. 1.3.3 Adult
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Hepatitis B Vaccines Market Dynamics
  1. 2.1 Hepatitis B Vaccines Industry Trends
  2. 2.2 Hepatitis B Vaccines Industry Drivers
  3. 2.3 Hepatitis B Vaccines Industry Opportunities and Challenges
  4. 2.4 Hepatitis B Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hepatitis B Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hepatitis B Vaccines Revenue by Region
  3. 3.2.1 Global Hepatitis B Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hepatitis B Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Hepatitis B Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Hepatitis B Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hepatitis B Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hepatitis B Vaccines Sales by Region
  9. 3.4.1 Global Hepatitis B Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hepatitis B Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Hepatitis B Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Hepatitis B Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hepatitis B Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Hepatitis B Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hepatitis B Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hepatitis B Vaccines Sales by Manufacturers
  6. 4.2.1 Global Hepatitis B Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hepatitis B Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hepatitis B Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hepatitis B Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hepatitis B Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hepatitis B Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Hepatitis B Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hepatitis B Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Hepatitis B Vaccines Tier 1, Tier 2, and Tier 3
5 Hepatitis B Vaccines Market by Type
  1. 5.1 Global Hepatitis B Vaccines Revenue by Type
  2. 5.1.1 Global Hepatitis B Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hepatitis B Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hepatitis B Vaccines Sales by Type
  6. 5.2.1 Global Hepatitis B Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hepatitis B Vaccines Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Hepatitis B Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hepatitis B Vaccines Price by Type
6 Hepatitis B Vaccines Market by Application
  1. 6.1 Global Hepatitis B Vaccines Revenue by Application
  2. 6.1.1 Global Hepatitis B Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hepatitis B Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hepatitis B Vaccines Sales by Application
  6. 6.2.1 Global Hepatitis B Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hepatitis B Vaccines Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Hepatitis B Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hepatitis B Vaccines Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Hepatitis B Vaccines Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 NCPC
  8. 7.2.1 NCPC Company Information
  9. 7.2.2 NCPC Business Overview
  10. 7.2.3 NCPC Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 NCPC Hepatitis B Vaccines Product Portfolio
  12. 7.2.5 NCPC Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Hepatitis B Vaccines Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Bio Kangtai
  20. 7.4.1 Bio Kangtai Company Information
  21. 7.4.2 Bio Kangtai Business Overview
  22. 7.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bio Kangtai Hepatitis B Vaccines Product Portfolio
  24. 7.4.5 Bio Kangtai Recent Developments
  25. 7.5 Dynavax
  26. 7.5.1 Dynavax Company Information
  27. 7.5.2 Dynavax Business Overview
  28. 7.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Dynavax Hepatitis B Vaccines Product Portfolio
  30. 7.5.5 Dynavax Recent Developments
  31. 7.6 Hissen
  32. 7.6.1 Hissen Company Information
  33. 7.6.2 Hissen Business Overview
  34. 7.6.3 Hissen Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hissen Hepatitis B Vaccines Product Portfolio
  36. 7.6.5 Hissen Recent Developments
  37. 7.7 KM Biologics
  38. 7.7.1 KM Biologics Company Information
  39. 7.7.2 KM Biologics Business Overview
  40. 7.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 KM Biologics Hepatitis B Vaccines Product Portfolio
  42. 7.7.5 KM Biologics Recent Developments
  43. 7.8 LG Life Sciences
  44. 7.8.1 LG Life Sciences Company Information
  45. 7.8.2 LG Life Sciences Business Overview
  46. 7.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 LG Life Sciences Hepatitis B Vaccines Product Portfolio
  48. 7.8.5 LG Life Sciences Recent Developments
  49. 7.9 Serum Institute
  50. 7.9.1 Serum Institute Company Information
  51. 7.9.2 Serum Institute Business Overview
  52. 7.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Serum Institute Hepatitis B Vaccines Product Portfolio
  54. 7.9.5 Serum Institute Recent Developments
8 North America
  1. 8.1 North America Hepatitis B Vaccines Market Size by Type
  2. 8.1.1 North America Hepatitis B Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Hepatitis B Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Hepatitis B Vaccines Price by Type (2021-2032)
  5. 8.2 North America Hepatitis B Vaccines Market Size by Application
  6. 8.2.1 North America Hepatitis B Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Hepatitis B Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Hepatitis B Vaccines Price by Application (2021-2032)
  9. 8.3 North America Hepatitis B Vaccines Market Size by Country
  10. 8.3.1 North America Hepatitis B Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hepatitis B Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hepatitis B Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hepatitis B Vaccines Market Size by Type
  2. 9.1.1 Europe Hepatitis B Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hepatitis B Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Hepatitis B Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Hepatitis B Vaccines Market Size by Application
  6. 9.2.1 Europe Hepatitis B Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hepatitis B Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Hepatitis B Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Hepatitis B Vaccines Market Size by Country
  10. 9.3.1 Europe Hepatitis B Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hepatitis B Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hepatitis B Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hepatitis B Vaccines Market Size by Type
  2. 10.1.1 China Hepatitis B Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Hepatitis B Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Hepatitis B Vaccines Price by Type (2021-2032)
  5. 10.2 China Hepatitis B Vaccines Market Size by Application
  6. 10.2.1 China Hepatitis B Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Hepatitis B Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Hepatitis B Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hepatitis B Vaccines Market Size by Type
  2. 11.1.1 Asia Hepatitis B Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hepatitis B Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Hepatitis B Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Hepatitis B Vaccines Market Size by Application
  6. 11.2.1 Asia Hepatitis B Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hepatitis B Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Hepatitis B Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Hepatitis B Vaccines Market Size by Country
  10. 11.3.1 Asia Hepatitis B Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hepatitis B Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hepatitis B Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hepatitis B Vaccines Market Size by Type
  2. 12.1.1 SAMEA Hepatitis B Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hepatitis B Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hepatitis B Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Hepatitis B Vaccines Market Size by Application
  6. 12.2.1 SAMEA Hepatitis B Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hepatitis B Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hepatitis B Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Hepatitis B Vaccines Market Size by Country
  10. 12.3.1 SAMEA Hepatitis B Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hepatitis B Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hepatitis B Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hepatitis B Vaccines Value Chain Analysis
  2. 13.1.1 Hepatitis B Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hepatitis B Vaccines Production Mode & Process
  6. 13.2 Hepatitis B Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hepatitis B Vaccines Distributors
  9. 13.2.3 Hepatitis B Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst